Crohns & Colitis 360

Scope & Guideline

Advancing knowledge in inflammatory bowel disease.

Introduction

Delve into the academic richness of Crohns & Colitis 360 with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherOXFORD UNIV PRESS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCROHNS COLITIS 360 / Crohns Colitis 360
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The journal 'Crohns & Colitis 360' focuses on advancing the understanding and management of inflammatory bowel disease (IBD), particularly Crohn's disease and ulcerative colitis. Its research encompasses a variety of methodologies, including clinical studies, systematic reviews, and qualitative research, aimed at improving patient outcomes through evidence-based practices.
  1. Clinical Management of IBD:
    Research aimed at optimizing treatment pathways, medication adherence, and clinical decision-making in the management of Crohn's disease and ulcerative colitis.
  2. Patient-Centric Research:
    Studies focusing on patient experiences, perspectives, and quality of life related to IBD, emphasizing the importance of patient engagement in treatment decisions.
  3. Innovative Therapeutics:
    Exploration of new therapeutic agents, including biologics and small molecules, and their efficacy, safety, and long-term outcomes in IBD treatment.
  4. Epidemiological and Health Economic Studies:
    Research investigating the prevalence, healthcare costs, and economic burden of IBD, providing insights into the broader impact of these diseases on healthcare systems.
  5. Use of Technology in IBD Management:
    Utilization of artificial intelligence, machine learning, and telehealth to enhance diagnostic accuracy, treatment adherence, and patient monitoring.
  6. Nutritional and Dietary Interventions:
    Exploration of the role of diet and nutrition in managing IBD symptoms and improving patient outcomes, including the effectiveness of dietary therapies.
Recent publications in 'Crohns & Colitis 360' indicate several emerging and trending themes that reflect the evolving landscape of IBD research. This section outlines these key areas of focus that are gaining traction.
  1. Real-World Evidence and Patient Outcomes:
    There is a growing emphasis on real-world studies that assess treatment effectiveness and patient-reported outcomes, highlighting the importance of understanding therapy impacts in everyday clinical settings.
  2. Telehealth and Remote Monitoring:
    Research exploring telehealth solutions and remote patient monitoring technologies is on the rise, especially in the context of increasing patient needs for accessible care and management during the COVID-19 pandemic.
  3. Psychosocial Factors in IBD:
    Emerging studies focus on the psychosocial aspects of living with IBD, including the impact of mental health on disease management and the importance of addressing psychological comorbidities.
  4. Diversity and Health Disparities:
    There is an increasing awareness and study of racial, ethnic, and geographic disparities in IBD care and outcomes, emphasizing the need for equitable healthcare access.
  5. Dietary Interventions and Personalized Nutrition:
    Research into dietary therapies and their role in managing IBD symptoms is expanding, with a focus on personalized nutritional approaches tailored to individual patient needs.

Declining or Waning

While many themes continue to thrive within 'Crohns & Colitis 360', certain areas of research appear to be waning in prominence. This section highlights those themes that are increasingly less represented in recent publications.
  1. Traditional Pharmacotherapy:
    Research focused exclusively on conventional medications for IBD, such as corticosteroids and thiopurines, seems to be declining as newer therapies gain attention.
  2. Surgical Interventions:
    The volume of studies addressing surgical management of IBD, including colectomies and resections, is decreasing, possibly due to a shift towards medical management and minimally invasive techniques.
  3. Basic Science and Mechanistic Studies:
    There is less emphasis on basic science research exploring the underlying mechanisms of IBD, as the journal increasingly prioritizes clinical and translational research.
  4. Single-Center Studies:
    The prevalence of single-center studies is diminishing in favor of multicenter collaborations that provide broader data and insights into IBD management.
  5. Conventional Epidemiological Studies:
    Traditional epidemiological research focusing solely on demographic trends in IBD without integrating patient-reported outcomes or economic evaluations appears to be less frequent.

Similar Journals

Minerva Gastroenterology

Pioneering Scholarly Excellence in Gastroenterology
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-5985Frequency: 4 issues/year

Minerva Gastroenterology, published by EDIZIONI MINERVA MEDICA, is a notable academic journal dedicated to advancing the field of gastroenterology and related disciplines. With an ISSN of 2724-5985 and an E-ISSN of 2724-5365, this journal gathers innovative research from diverse areas including internal medicine, endocrinology, and metabolism. Though characterized by its open-access policies, Minerva Gastroenterology aims to provide a platform for high-quality scholarly articles with an emphasis on critical reviews, clinical studies, and translational research. Since its inception in 2021, the journal has managed to secure a reputation reflected in its Q3 rank across multiple categories in 2023, as well as its standing in Scopus rankings, positioning it in the 45th to 47th percentile among renowned medical journals. Situated in Turin, Italy, it fosters collaboration and knowledge-sharing among researchers and practitioners, making it an essential resource for those seeking to deepen their understanding of gastroenterological conditions and enhance clinical practices.

INFLAMMATORY BOWEL DISEASES

Transforming insights into effective treatments.
Publisher: OXFORD UNIV PRESS INCISSN: 1078-0998Frequency: 12 issues/year

INFLAMMATORY BOWEL DISEASES is a premier journal published by Oxford University Press, Inc., dedicated to advancing research within the fields of gastroenterology and immunology. With an impressive impact factor reflecting its status as a Q1 category journal in both gastroenterology and immunology and allergy, it ranks 17th out of 167 in gastroenterology and 53rd out of 233 in immunology, underscoring its influence and authority within the scientific community. Since its inception in 1995 and continuing through to 2024, the journal has become an essential resource for researchers, healthcare professionals, and students, serving as a platform for the latest findings in the diagnosis, treatment, and management of inflammatory bowel diseases. While the journal operates under a subscription-based model, it is recognized for its rigorous peer-review process and commitment to publishing high-caliber, impactful studies that contribute significantly to understanding and treating these complex conditions.

Saudi Journal of Gastroenterology

Connecting researchers to the latest in gastroenterology.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.

JGH Open

Elevating Research, Enhancing Lives
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Therapeutic Advances in Gastroenterology

Exploring breakthroughs in digestive health.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-283XFrequency: 1 issue/year

Therapeutic Advances in Gastroenterology, published by SAGE Publications Ltd, is a premier open access journal dedicated to the advancement of knowledge in the field of gastroenterology. Since its inception in 2008 and its transition to open access in 2018, the journal has consistently provided high-quality peer-reviewed research articles, review papers, and clinical studies that address the latest therapeutic advancements and challenges in gastrointestinal medicine. With an impressive impact factor and a 2023 Scopus ranking placing it in the Q1 quartile of gastroenterology journals, it stands as a leading platform for researchers, clinicians, and healthcare professionals. The journal’s commitment to disseminating impactful research has positioned it at the forefront of academic discourse, offering a vital resource for those devoted to improving patient outcomes in digestive health. The United Kingdom-based journal invites submissions that contribute to the understanding and treatment of gastrointestinal disorders, ensuring that cutting-edge findings reach a global audience.

GUT

Pioneering Research for Digestive Health Excellence
Publisher: BMJ PUBLISHING GROUPISSN: 0017-5749Frequency: 12 issues/year

GUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.

Nature Reviews Gastroenterology & Hepatology

Elevating Standards in Gastroenterology & Hepatology
Publisher: NATURE PORTFOLIOISSN: 1759-5045Frequency: 12 issues/year

Nature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Charting New Frontiers in Gastrointestinal Medicine
Publisher: WILEYISSN: 0269-2813Frequency: 24 issues/year

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, published by Wiley, is a premier scholarly journal in the fields of gastroenterology, hepatology, and pharmacology. With an impressive impact factor and ranking in the top quartile (Q1) of its classifications, the journal is recognized for its rigorous peer-reviewed research and comprehensive reviews, aiming to advance the understanding of therapeutic interventions in gastrointestinal and liver diseases. Since its inception in 1987, it has become an essential resource for researchers, healthcare professionals, and students alike, fostering scientific dialogue and innovation. With a Scopus rank placing it in the 97th percentile for pharmacology and 96th for gastroenterology, it is dedicated to publishing the most significant and impactful findings in the field. ALIMENTARY PHARMACOLOGY & THERAPEUTICS thus plays a vital role in shaping the future of medical treatments and interventions in gastrointestinal health.

Intestinal Research

Pioneering Research for Better Intestinal Care
Publisher: KOREAN ASSOC STUDY INTESTINAL DISEASESISSN: 1598-9100Frequency: 4 issues/year

Intestinal Research is an influential open-access journal dedicated to advancing knowledge in the field of gastroenterology. Published by the Korean Association for the Study of Intestinal Diseases, this journal has been providing valuable insights into intestinal health since its inception in 2003. With an impressive impact factor and a current ranking of Q2 in the gastroenterology category, it is recognized among the top journals in its field, achieving a remarkable 82nd percentile in Scopus rankings. Based in South Korea, the journal's mission is to facilitate research and discussions on intestinal diseases, pathophysiology, innovative treatments, and advancements in care practices. By offering open access, Intestinal Research ensures that critical findings are readily available to researchers, healthcare professionals, and students alike, fostering global collaboration and sharing of knowledge. The journal accepts contributions that reflect the latest developments and foster deep understanding within the intestinal disease research community.

Indian Journal of Gastroenterology

Connecting Researchers and Practitioners in Gastroenterology
Publisher: SPRINGER INDIAISSN: 0254-8860Frequency: 6 issues/year

The Indian Journal of Gastroenterology, a prominent publication in the field of gastroenterology, is published by Springer India. With roots dating back to 1982 and an ongoing commitment to disseminating high-quality research, this journal serves as a vital platform for researchers, practitioners, and students interested in gastrointestinal health and diseases. It boasts an impressive track record with a Scopus rank of #82 in the gastroenterology category and a 2023 quartile ranking of Q3, firmly situating it within the competitive landscape of medical journals. Although it is not an open-access journal, the Indian Journal of Gastroenterology offers accessible research articles contributing significantly to the field, facilitating informed discussion and advancing knowledge in gastrointestinal medicine. The journal's comprehensive focus covers a wide range of topics from clinical studies to innovative therapeutic approaches, ensuring its relevance to current medical practices and the evolving challenges in gastroenterology.